1. Home
  2. VANI vs MCN Comparison

VANI vs MCN Comparison

Compare VANI & MCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vivani Medical Inc. (DE)

VANI

Vivani Medical Inc. (DE)

HOLD

Current Price

$1.19

Market Cap

119.0M

Sector

Health Care

ML Signal

HOLD

Logo Madison Covered Call & Equity Strategy Fund

MCN

Madison Covered Call & Equity Strategy Fund

HOLD

Current Price

$5.45

Market Cap

118.4M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
VANI
MCN
Founded
1998
2004
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
119.0M
118.4M
IPO Year
2014
2004

Fundamental Metrics

Financial Performance
Metric
VANI
MCN
Price
$1.19
$5.45
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$3.50
N/A
AVG Volume (30 Days)
203.0K
45.2K
Earning Date
05-14-2026
01-01-0001
Dividend Yield
N/A
9.96%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,000,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.92
$5.45
52 Week High
$1.92
$6.39

Technical Indicators

Market Signals
Indicator
VANI
MCN
Relative Strength Index (RSI) 34.97 25.11
Support Level $1.13 N/A
Resistance Level $1.25 $5.69
Average True Range (ATR) 0.07 0.05
MACD -0.02 -0.03
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
VANI
MCN

About VANI Vivani Medical Inc. (DE)

Vivani Medical Inc is a clinical stage biopharmaceutical company which develops miniature, ultra long-acting subdermal drug implant candidates utilizing its proprietary NanoPortal technology, which is designed to enable reversible, ultra long-acting, near constant-rate delivery of a broad range of medicines to treat chronic diseases. Vivani uses this platform technology to develop, and potentially commercialize, drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases, including medication non-adherence, drug tolerability and administration challenges faced by certain patients. It operates in two segments the Biopharm Division and Neurostimulation Division.

About MCN Madison Covered Call & Equity Strategy Fund

XAI Madison Equity Premium Income Fund is an investment management company. The Fund invests in an actively managed equity portfolio comprised of individual stocks and covered call options. The Fund's primary investment objective is to provide high level of current income and gains, with a secondary objective of capital appreciation.

Share on Social Networks: